Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Infants with PWS genetically confirmed~* Aged less than 5 months~Exclusion Criteria:~* Infants presenting hepatic insufficiency~* Infants presenting renal insufficiency~* Infants with abnormal ECG

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 5 Months
- Healthy Volunteers: f

Study Arms:
- first arm (Type: ACTIVE_COMPARATOR): 4IU of oxytocin every other day
- second arm (Type: ACTIVE_COMPARATOR): 4 IU of oxytocin daily
- third arm (Type: ACTIVE_COMPARATOR): 4 IU of oxytocin twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).